Hepatocellular Carcinoma New Protocol: Tremelimumab and Durvalumab for HCC Ulas D. Bayraktar, MD 2023-01-10
Follicular Lymphoma New Drug: Mosunetuzumab for R/R Follicular Lymphoma Ulas D. Bayraktar, MD 2023-01-10
Non-Small Cell Lung Cancer New Protocol: Cemiplimab with Chemotherapy in NSCLC Ulas D. Bayraktar, MD 2023-01-10
Non-Small Cell Lung Cancer New Indication: Durvalumab with Tremelimumab in Metastatic NSCLC Ulas D. Bayraktar, MD 2023-01-10
Other diagnosis New Indication: Avelumab and Axitinib in Thymic Carcinoma Ulas D. Bayraktar, MD 2022-11-26
Non-Small Cell Lung Cancer New Indication: Adjuvant Pembrolizumab in NSCLC Ulas D. Bayraktar, MD 2022-11-26
Non-Small Cell Lung Cancer New Drug: Selpercatinib in RET-Fusion Positive NSCLC Ulas D. Bayraktar, MD 2022-11-26
Diffuse Large B Cell Lymphoma New Indication: Polatuzumab in Untreated DLBCL Ulas D. Bayraktar, MD 2022-11-26
